Gary K. Steinberg

Active 1982–2025

193
Papers
30,784
Citations
104
h-index
186
i10-index

Citations

Citations per year for Gary K. Steinberg1984: 1 citations1988: 7 citations1989: 14 citations1990: 17 citations1991: 8 citations1992: 25 citations1993: 21 citations1994: 22 citations1995: 24 citations1996: 53 citations1997: 44 citations1998: 65 citations1999: 86 citations2000: 85 citations2001: 96 citations2002: 128 citations2003: 128 citations2004: 123 citations2005: 147 citations2006: 144 citations2007: 162 citations2008: 221 citations2009: 262 citations2010: 175 citations2011: 216 citations2012: 237 citations2013: 216 citations2014: 251 citations2015: 223 citations2016: 241 citations2017: 340 citations2018: 275 citations2019: 956 citations2020: 1,010 citations2021: 992 citations2022: 764 citations2023: 597 citations2024: 868 citations2025: 411 citations2026: 13 citations1985–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,859 citing papers, 32% of this breakdownChina: 1,733 citing papers, 14.4% of this breakdownUnited Kingdom: 641 citing papers, 5.3% of this breakdownGermany: 619 citing papers, 5.1% of this breakdownCanada: 473 citing papers, 3.9% of this breakdownJapan: 401 citing papers, 3.3% of this breakdownItaly: 367 citing papers, 3.1% of this breakdownFrance: 364 citing papers, 3% of this breakdownNetherlands: 285 citing papers, 2.4% of this breakdownAustralia: 270 citing papers, 2.3% of this breakdownSouth Korea: 270 citing papers, 2.2% of this breakdownSpain: 264 citing papers, 2.2% of this breakdown
0%32%Other 20.8%

Fields

  • Medicine45.3%
  • Neuroscience23.1%
  • Biochemistry, Genetics and Molecular Biology17.5%
  • Immunology and Microbiology8.9%
  • Engineering2.8%
  • Materials Science0.9%
  • Other1.5%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms6.4%
  • Intracranial Aneurysms: Treatment and Complications3.2%
  • Neurogenesis and neuroplasticity mechanisms3.1%
  • Immune cells in cancer2.7%
  • Vascular Malformations Diagnosis and Treatment2.6%
  • Phagocytosis and Immune Regulation2.5%
  • Other79.5%

Coauthors

All papers

Open in search
  1. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse

    Authors: , , , , , , , , , , , , , , , , - Neuron 2015 cited by 2,456

  2. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diane Tseng, Siddhartha Jaiswal, Per Øyvind Enger, Gary K. Steinberg, Gordon Li, Samuel So, Ravindra Majeti, Griffith R. Harsh, Matt van de Rijn, Nelson N.H. Teng, John B. Sunwoo, Ash A. Alizadeh, Michael F. Clarke, Irving L. Weissman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 1,665

  3. Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke

    Authors: , , , , , , , , , - Neuron 2014 cited by 712

  4. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Vogel, Michael S. B. Edwards, Irving L. Weissman, Samuel Cheshier - Science Translational Medicine 2017 cited by 425

  5. Moyamoya disease: diagnosis and interventions

    Authors: , , , , , , , , , , , , - The Lancet Neurology 2022 cited by 357

  6. Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments

    Authors: , - Neuron 2015 cited by 388

  7. Stroke Treatment Academic Industry Roundtable X

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nerses Sanossian, Lee H. Schwamm, Magdy Selim, Kevin N. Sheth, Judith Spilker, Yoram Solberg, Gary K. Steinberg, Steven L. Stice, Michael Tymianski, Lawrence R. Wechsler, Albert J. Yoo - Stroke 2019 cited by 192

  8. A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke

    Authors: , , , , , , , , - Nature Biomedical Engineering 2021 cited by 138

  9. A Review of Magnetic Particle Imaging and Perspectives on Neuroimaging

    Authors: , , , , , , , , , , , , , , , - American Journal of Neuroradiology 2019 cited by 205

  10. Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke

    Authors: , , , , , , , , , , , , , - Stroke 2016 cited by 388

  11. A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury

    Authors: , , , , , , , - Journal of Neurosurgery Spine 2022 cited by 61

  12. Multimodal image registration and connectivity analysis for integration of connectomic data from microscopy to MRI

    Authors: , , , , , , , , , , , - Nature Communications 2019 cited by 111

  13. Optogenetic neuronal stimulation promotes functional recovery after stroke

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 213

  14. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke

    Authors: , , - Journal of Neuroscience Research 2008 cited by 241

  15. Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury.

    Authors: , , , , , , , - Journal of Neurosurgery Spine 2022 cited by 36

  16. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain

    Authors: , , , , , , , , , , , , , - Brain 2011 cited by 330

  17. Cell Therapy for Chronic TBI

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2021 cited by 82

  18. Thrombospondins 1 and 2 are Necessary for Synaptic Plasticity and Functional Recovery after Stroke

    Authors: , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2008 cited by 268

  19. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow–derived mesenchymal stem cells (SB623): a phase 1/2a study

    Authors: , , , , , , , , , , , - Journal of neurosurgery 2019 cited by 150

  20. Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target

    Authors: , , , , , , , , , , , , , , , , , - Brain 2015 cited by 129

  21. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features

    Authors: , , , , , , , , , - Radiology 2014 cited by 320

  22. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis

    Authors: , , , , - Human Molecular Genetics 2008 cited by 286

  23. Translational Stroke Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudia S. Moy, Miguel A. Pérez‐Pinzón, Ipolia Ramadan, Sean I. Savitz, Lee H. Schwamm, Gary K. Steinberg, Mary P. Stenzel‐Poore, Michael Tymianski, Steven Warach, Lawrence R. Wechsler, John H. Zhang, Walter J. Koroshetz - Stroke 2017 cited by 172

  24. Stem Cells as an Emerging Paradigm in Stroke 4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franklin D. West, Farhaan Vahidy, Dorothy E. Vawter, Dileep R. Yavagal, Bing Yang, Ludvic Zrinzo - Stroke 2019 cited by 92